144 related articles for article (PubMed ID: 34495482)
1. A case of pancreatic neuroendocrine carcinoma with a favorable clinical response to pembrolizumab.
Kogami T; Iwai T; Kida M; Okuwaki K; Hasegawa R; Kurosu T; Watanabe M; Matsushita M; Imawari K; Adachi K; Tadehara M; Tamaki A; Imaizumi H; Koizumi W
Clin J Gastroenterol; 2021 Dec; 14(6):1804-1810. PubMed ID: 34495482
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic neuroendocrine carcinoma G3 may be heterogeneous and could be classified into two distinct groups.
Tanaka H; Hijioka S; Hosoda W; Ueno M; Kobayashi N; Ikeda M; Ito T; Kodama Y; Morizane C; Notohara K; Taguchi H; Kitano M; Komoto I; Tsuji A; Hashigo S; Kanno A; Miyabe K; Takagi T; Ishii H; Kojima Y; Yoshitomi H; Yanagimoto H; Furuse J; Mizuno N
Pancreatology; 2020 Oct; 20(7):1421-1427. PubMed ID: 32891532
[TBL] [Abstract][Full Text] [Related]
3. [A CASE OF URACHAL CARCINOMA WITH HIGH FREQUENCY MICROSATELLITE INSTABILITY (MSI-HIGH) TREATED BY PEMBROLIZUMAB].
Tokita T; Iuchi S; Noto N; Hashizume A; Higuchi K; Miyama K; Kawai M; Nakamura K
Nihon Hinyokika Gakkai Zasshi; 2022; 113(2):68-72. PubMed ID: 37081655
[TBL] [Abstract][Full Text] [Related]
4. Complete response to pembrolizumab in advanced hepatocellular carcinoma with microsatellite instability.
Ando Y; Yamauchi M; Suehiro Y; Yamaoka K; Kosaka Y; Fuji Y; Uchikawa S; Kodama K; Morio K; Fujino H; Nakahara T; Ono A; Murakami E; Kawaoka T; Takahashi S; Tsuge M; Hiramatsu A; Imamura M; Chayama K; Aikata H
Clin J Gastroenterol; 2020 Oct; 13(5):867-872. PubMed ID: 32020539
[TBL] [Abstract][Full Text] [Related]
5. Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
André T; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt C; Smith D; Garcia-Carbonero R; Benavides M; Gibbs P; de la Fouchardiere C; Rivera F; Elez E; Bendell J; Le DT; Yoshino T; Van Cutsem E; Yang P; Farooqui MZH; Marinello P; Diaz LA;
N Engl J Med; 2020 Dec; 383(23):2207-2218. PubMed ID: 33264544
[TBL] [Abstract][Full Text] [Related]
6. [MSI-H Small Bowel Cancer with Peritoneal Dissemination Successfully Treated with Pembrolizumab-A Case Report].
Moriuchi T; Shimizu Y; Shimizu W; Sada H; Kubota H; Tahara S; Komo T; Hadano N; Tazawa H; Suzuki T; Onoe T; Ishiyama K; Sudo T; Tashiro H
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2009-2011. PubMed ID: 33468783
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Advanced Recurrent Colorectal Cancer with Complete Response to Pembrolizumab Chemotherapy].
Ishiguro T; Ishikawa H; Muta Y; Ito T; Chikatani K; Chika N; Amano K; Hatano S; Suzuki O; Mori Y; Kumagai Y; Ishibashi K; Mochiki E; Ishida H
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2299-2301. PubMed ID: 33468940
[TBL] [Abstract][Full Text] [Related]
8. Mixed acinar-neuroendocrine carcinoma of the pancreas with positive for microsatellite instability: a case report and review of the literature.
Yoshino K; Kasai Y; Kurosawa M; Itami A; Takaori K
Surg Case Rep; 2023 Jun; 9(1):122. PubMed ID: 37386324
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report.
Toshida K; Itoh S; Yoshizumi T; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Oki E; Nakamura Y; Yoshino T; Mori M
Clin J Gastroenterol; 2021 Oct; 14(5):1459-1463. PubMed ID: 34085164
[TBL] [Abstract][Full Text] [Related]
10. Effective Response of Intrahepatic Cholangiocarcinoma to Pembrolizumab: A Case Report.
Nakamura M; Ueno M; Hayami S; Kawai M; Miyamoto A; Suzaki N; Hirono S; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Kojima F; Yamaue H
Anticancer Res; 2020 Jul; 40(7):4123-4129. PubMed ID: 32620661
[TBL] [Abstract][Full Text] [Related]
11. A case of pancreatic mixed acinar-neuroendocrine carcinoma successfully diagnosed with endoscopic ultrasound-guided fine needle aspiration.
Niiya F; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Norose T; Ohike N; Nagahama M
Clin J Gastroenterol; 2020 Oct; 13(5):951-958. PubMed ID: 32529486
[TBL] [Abstract][Full Text] [Related]
12. [Experience of Pembrolizumab Administration in A Patient with Castration-Resistant Microsatellite Instability-High Prostate Cancer].
Takasawa T; Amano T; Himeno M; Imao T
Hinyokika Kiyo; 2024 Feb; 70(2):51-54. PubMed ID: 38447945
[TBL] [Abstract][Full Text] [Related]
13. Medullary carcinoma of the duodenum treated with pembrolizumab: a case report.
Liu L; Kaur S; Dayyani F; Cho M; Ran-Castillo D; Chong E; Khandelwal K; Demisse R
J Gastrointest Oncol; 2023 Apr; 14(2):1149-1154. PubMed ID: 37201040
[TBL] [Abstract][Full Text] [Related]
14. Pembrolizumab in advanced recurrent endometrial cancer: A cost-effectiveness analysis.
Barrington DA; Dilley SE; Smith HJ; Straughn JM
Gynecol Oncol; 2019 May; 153(2):381-384. PubMed ID: 30808517
[TBL] [Abstract][Full Text] [Related]
15. Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA.
Barata P; Agarwal N; Nussenzveig R; Gerendash B; Jaeger E; Hatton W; Ledet E; Lewis B; Layton J; Babiker H; Bryce A; Garje R; Stein C; Kiedrowski L; Saylor P; Sartor O
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32788235
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine carcinoma of the gastric stump: A case report and literature review.
Ma FH; Xue LY; Chen YT; Xie YB; Zhong YX; Xu Q; Tian YT
World J Gastroenterol; 2018 Jan; 24(4):543-548. PubMed ID: 29398875
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine carcinoma of the pancreas with similar genetic alterations to invasive ductal adenocarcinoma.
Kimura T; Miyamoto H; Fukuya A; Kitamura S; Okamoto K; Kimura M; Muguruma N; Ikemoto T; Shimada M; Yoneda A; Bando Y; Takishita M; Takayama T
Clin J Gastroenterol; 2016 Aug; 9(4):261-5. PubMed ID: 27262570
[TBL] [Abstract][Full Text] [Related]
18. Pseudoprogression of lung large cell neuroendocrine carcinoma resembling pancreatic cancer during durvalumab therapy.
Hattori A; Nishikawa K; Ito K; Tachikawa N; Fujibe K; Tanaka S; Oiwa M; Hataji O
Clin J Gastroenterol; 2022 Jun; 15(3):668-672. PubMed ID: 34984635
[TBL] [Abstract][Full Text] [Related]
19. Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.
Bruera G; Giuliani A; Romano L; Chiominto A; Di Sibio A; Mastropietro S; Cosenza P; Ricevuto E; Schietroma M; Carlei F;
BMC Cancer; 2019 Oct; 19(1):960. PubMed ID: 31619203
[TBL] [Abstract][Full Text] [Related]
20. [A Case of Primary Neuroendocrine Carcinoma of the Retroperitoneum].
Fukushima M; Otaki T; Usui Y
Hinyokika Kiyo; 2021 Sep; 67(9):423-426. PubMed ID: 34610708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
